NDC 59676-580

Janssen COVID-19 Vaccine

Jnj-78436735

Janssen COVID-19 Vaccine is a Intramuscular Suspension in the Vaccine category. It is labeled and distributed by Janssen Products, Lp. The primary component is Jnj-78436735.

Product ID59676-580_598fd038-6387-11ea-a1ca-cee9fb2ca371
NDC59676-580
Product TypeVaccine
Proprietary NameJanssen COVID-19 Vaccine
Generic NameJnj-78436735
Dosage FormSuspension
Route of AdministrationINTRAMUSCULAR
Marketing Start Date2021-01-04
Marketing CategoryUNAPPROVED DRUG OTHER /
Labeler NameJanssen Products, LP
Substance NameJNJ-78436735
Active Ingredient Strength2147483647 [PFU]/.5mL
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 59676-580-05

10 VIAL, MULTI-DOSE in 1 CARTON (59676-580-05) > 2.5 mL in 1 VIAL, MULTI-DOSE (59676-580-15)
Marketing Start Date2021-01-04
NDC Exclude FlagN
Sample Package?N

Drug Details


© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.